Apoptosis and necroptosis in the liver: a matter of life and death

RF Schwabe, T Luedde - Nature reviews Gastroenterology & …, 2018 - nature.com
Cell death represents a basic biological paradigm that governs outcomes and long-term
sequelae in almost every hepatic disease condition. Acute liver failure is characterized by …

The biology of Hepatocellular carcinoma: implications for genomic and immune therapies

G Khemlina, S Ikeda, R Kurzrock - Molecular cancer, 2017 - Springer
Hepatocellular carcinoma (HCC), the most common type of primary liver cancer, is a leading
cause of cancer-related death worldwide. It is highly refractory to most systemic therapies …

[HTML][HTML] Current and future treatment of hepatocellular carcinoma: an updated comprehensive review

S Daher, M Massarwa, AA Benson… - Journal of clinical and …, 2018 - ncbi.nlm.nih.gov
Hepatocellular carcinoma (HCC) is among the leading causes of cancer-related mortality.
The principal treatment is surgical resection or liver transplantation, depending on whether …

Retracted: IL‐6/STAT3 pathway intermediates M1/M2 macrophage polarization during the development of hepatocellular carcinoma

Z Yin, T Ma, Y Lin, X Lu, C Zhang… - Journal of cellular …, 2018 - Wiley Online Library
Human cancers, including hepatocellular carcinoma (HCC), are characterized by a high
degree of drug resistance in chemotherapy. However, the underlying molecular mechanism …

Recent advances in nanomaterials for sonodynamic therapy

T Xu, S Zhao, C Lin, X Zheng, M Lan - Nano Research, 2020 - Springer
Sonodynamic therapy (SDT), as a novel non-invasive strategy for eliminating tumor, has the
advantages of deeper tissue penetration, fewer side effects, and better patient compliance …

Recent advances in nanogold as a promising nanocarrier for curcumin delivery

A Mahmoudi, P Kesharwani, M Majeed, Y Teng… - Colloids and Surfaces B …, 2022 - Elsevier
Curcumin is a natural polyphenolic compound that has promising therapeutic benefits.
However, curcumin suffers from low aqueous solubility and poor bioavailability following …

The miR-30a-5p/CLCF1 axis regulates sorafenib resistance and aerobic glycolysis in hepatocellular carcinoma

Z Zhang, X Tan, J Luo, H Yao, Z Si, JS Tong - Cell death & disease, 2020 - nature.com
HCC (hepatocellular carcinoma) is a major health threat for the Chinese population and has
poor prognosis because of strong resistance to chemotherapy in patients. For instance, a …

Glycyrrhetinic acid mediated drug delivery carriers for hepatocellular carcinoma therapy

Y Cai, Y Xu, HF Chan, X Fang, C He… - Molecular …, 2016 - ACS Publications
Glycyrrhetinic acid (GA), the main hydrolysate of glycyrrhizic acid extracted from the root of
licorice, has been used in hepatocellular carcinoma (HCC) therapy. Particularly, GA as a …

[HTML][HTML] Three dimensional mixed-cell spheroids mimic stroma-mediated chemoresistance and invasive migration in hepatocellular carcinoma

IA Khawar, JK Park, ES Jung, MA Lee, S Chang… - Neoplasia, 2018 - Elsevier
Interactions between cancer cells and cancer-associated fibroblasts (CAFs) within the tumor
microenvironment (TME) play an important role in promoting the profibrotic …

[HTML][HTML] New insights into autophagy in hepatocellular carcinoma: mechanisms and therapeutic strategies

S Yang, L Yang, X Li, B Li, Y Li, X Zhang… - American Journal of …, 2019 - ncbi.nlm.nih.gov
Autophagy is a mechanism by which cellular substances are transported to lysosomes for
degradation, allowing the basic transformation of cellular components, and providing energy …